|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/09 | (2006.01) |
| A61P 1/16 | (2006.01) | ||
| A61K 31/192 | (2006.01) |
| (11) | Number of the document | 3119384 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15714132.6 |
| Date of filing the European patent application | 2015-03-19 | |
| (97) | Date of publication of the European application | 2017-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-12 |
| (46) | Date of publication of the claims translation | 2018-11-26 |
| (86) | Number | PCT/US2015/021502 |
| Date | 2015-03-19 |
| (87) | Number | WO 2015/143178 |
| Date | 2015-09-24 |
| (30) | Number | Date | Country code |
| 201461968037 P | 2014-03-20 | US |
| (72) |
BOUDES, Pol, US
MCWHERTER, Charles, A., US
|
| (73) |
CymaBay Therapeutics, Inc.,
333 Lakeside Drive, Foster City, 94404 CA,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Intrahepatinių cholestazinių ligų gydymas |
| TREATMENT OF INTRAHEPATIC CHOLESTATIC DISEASES |
| Payment date | Validity (years) | Amount | |
| 2026-02-23 | 12 | 289.00 EUR |
| 2027-03-19 |